These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38953436)

  • 1. A community-based participatory research approach to evaluating and improving hepatitis C risk, knowledge, and stigma associations among people who inject substances in Indiana.
    Woodward B; Millar K; Carter G
    Public Health Nurs; 2024; 41(5):961-969. PubMed ID: 38953436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug use-related stigma, safer injection norms, and hepatitis C infection among a network-based sample of young people who inject drugs.
    Williams LD; Mackesy-Amiti ME; Latkin C; Boodram B
    Drug Alcohol Depend; 2021 Apr; 221():108626. PubMed ID: 33689967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using an intersectionality lens to explore barriers and enablers to hepatitis C point-of-care testing: a qualitative study among people who inject drugs and service providers.
    Fontaine G; Presseau J; Bruneau J; Etherington C; Thomas IM; Hung JC; van Allen Z; Patey AM; Kareem A; Mortazhejri S; Høj SB; Boyer-Legault G; Grimshaw JM
    Int J Equity Health; 2024 Jun; 23(1):124. PubMed ID: 38886803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study.
    Marshall AD; Rance J; Dore GJ; Grebely J; Treloar C
    Int J Drug Policy; 2024 Jul; 129():104477. PubMed ID: 38861842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community Perceptions of Comprehensive Harm Reduction Programs and Stigma Towards People Who Inject Drugs in Rural Virginia.
    Baker LS; Smith W; Gulley T; Tomann MM
    J Community Health; 2020 Apr; 45(2):239-244. PubMed ID: 31502098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Values and preferences for hepatitis C self-testing among people who inject drugs in Kyrgyzstan.
    Martínez-Pérez GZ; Nikitin DS; Bessonova A; Fajardo E; Bessonov S; Shilton S
    BMC Infect Dis; 2021 Jun; 21(1):609. PubMed ID: 34171990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs.
    Treloar C; Hull P; Bryant J; Hopwood M; Grebely J; Lavis Y
    Drug Alcohol Depend; 2011 Jul; 116(1-3):52-6. PubMed ID: 21194852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs.
    Broady TR; Valerio H; Alavi M; Wheeler A; Silk D; Martinello M; Conway A; Milat A; Dunlop A; Murray C; Henderson C; Amin J; Read P; Marks P; Degenhardt L; Stevens A; Prain B; Hayllar J; Reid D; Montebello M; Wade A; Christmass M; Cock V; Dore GJ; Treloar C; Grebely J;
    Int J Drug Policy; 2024 Jun; 128():104468. PubMed ID: 38795465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "They look at us like junkies": influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City.
    Muncan B; Walters SM; Ezell J; Ompad DC
    Harm Reduct J; 2020 Jul; 17(1):53. PubMed ID: 32736624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health care-seeking experiences for people who inject drugs with hepatitis C: Qualitative explorations of stigma.
    Austin EJ; Tsui JI; Barry MP; Tung E; Glick SN; Ninburg M; Williams EC
    J Subst Abuse Treat; 2022 Jun; 137():108684. PubMed ID: 34911656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users.
    Cox J; De P; Morissette C; Tremblay C; Stephenson R; Allard R; Graves L; Roy E
    Soc Sci Med; 2008 Jan; 66(2):211-20. PubMed ID: 17920741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India.
    Clipman SJ; Mehta SH; Srikrishnan AK; Zook KJ; Duggal P; Mohapatra S; Shanmugam S; Nandagopal P; Kumar MS; Ogburn E; Lucas GM; Latkin CA; Solomon SS
    Elife; 2021 Aug; 10():. PubMed ID: 34342266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India.
    Patel EU; Solomon SS; Mcfall AM; Srikrishnan AK; Pradeep A; Nandagopal P; Laeyendecker O; Tobian AAR; Thomas DL; Sulkowski MS; Kumar MS; Mehta SH
    Int J Drug Policy; 2018 Jul; 57():51-60. PubMed ID: 29679811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-finding for hepatitis C in primary care: a mixed-methods service evaluation.
    Datta S; Horwood J; Hickman M; Sharp D
    Br J Gen Pract; 2014 Feb; 64(619):e67-74. PubMed ID: 24567619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing patterns in HIV/AIDS stigma and uptake of voluntary counselling and testing services: the results of two consecutive community surveys conducted in the Western Cape, South Africa.
    Mall S; Middelkoop K; Mark D; Wood R; Bekker LG
    AIDS Care; 2013; 25(2):194-201. PubMed ID: 22694602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low knowledge and perceived Hepatitis C risk despite high risk behaviour among injection drug users in Kathmandu, Nepal.
    Loewinger G; Sharma B; Karki DK; Khatiwoda P; Kainee S; Poudel KC
    Int J Drug Policy; 2016 Jul; 33():75-82. PubMed ID: 27318773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of HIV knowledge and stigma on the uptake of HIV testing - Results from a community-based participatory research survey among migrants from sub-Saharan Africa in Germany.
    Kuehne A; Koschollek C; Santos-Hövener C; Thorlie A; Müllerschön J; Mputu Tshibadi C; Mayamba P; Batemona-Abeke H; Amoah S; Wangare Greiner V; Dela Bursi T; Bremer V
    PLoS One; 2018; 13(4):e0194244. PubMed ID: 29641527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The eliminate hepatitis C (EC) experience study: baseline characteristics of a cohort of people who inject drugs in Melbourne, Australia.
    Gunn J; O'Keefe D; Draper BL; Djordjevic F; Ryan K; Kerr P; Elsum I; Gold J; Layton C; Chan K; Dietze P; Higgs P; Doyle J; Stoové MA; Hellard M; Pedrana A
    BMJ Open; 2023 Jul; 13(7):e071665. PubMed ID: 37400235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
    Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
    BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018.
    Meyerson BE; Lawrence CA; Cope SD; Levin S; Thomas C; Eldridge LA; Coles HB; Vadiei N; Kennedy A
    Harm Reduct J; 2019 Sep; 16(1):57. PubMed ID: 31533730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.